primary human glomerular microvascular endothelial cells Search Results


N/A
Human Glomerular Microvascular Endothelial Cells (HGMEC) - Cryopreserved, 0.5 million cells/vial
  Buy from Supplier

94
Angio-Proteomie human glomerular endothelial cells hgecs
a The changes of [Ca 2+ ]i in <t>HGECs</t> exposed to cinacalcet and high-glucose media. To determine whether the addition of cinacalcet might modulate [Ca 2+ ]i in HGECs, FURA-2AM-loaded HGECs were stimulated using different concentrations (15, 100 nM) of cinacalcet in low-glucose (LG; 5 mmol/l D-glucose) or high-glucose (HG; 30 mmol/l D-glucose) media. The area under curve (AUC) was estimated from the baseline of normalized data (at the point of injection) to a fluorescence level and between time points of injection (0 min) and 10 min. The peak of the curve was measured as highest value of the curve. The peak amplitude and AUC of [Ca 2+ ]i were significantly increased by cinacalcet in dose-dependent manners in both LG and HG media. In Fig. 1a, the arrow denotes the administration of cinacalcet (15 and 100 nM, respectively) ( n = 6 independent experiments in each experiments). * p < 0.05; ** p < 0.01 compared with LG and HG. b The changes of intracellular signaling in HGECs exposed to cinacalcet and high-glucose media. Representative immunofluorescent ( n = 6 independent experiments in each experiments) and western blot analyses ( n = 4 independent experiments in each experiments) of CaSR, CaMKKα/β, phospho-Ser 428 LKB1, and phospho-Thr 172 AMPK in the cultured HGECs in low-glucose (LG; 5 mmol/l D-glucose) or high-glucose (HG; 30 mmol/l D-glucose) conditions with or without cinacalcet treatment (15 nM) and the quantitative analyses of the results are shown. * P < 0.05; ** P < 0.01 and # P < 0.001 compared with other groups
Human Glomerular Endothelial Cells Hgecs, supplied by Angio-Proteomie, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/primary+human+glomerular+microvascular+endothelial+cells/Human+Glomerular+Microvascular+Endothelial+Cells/pmc05833853-67-0-16
Average 94 stars, based on 1 article reviews
human glomerular endothelial cells hgecs - by Bioz Stars, 2026-09
94/100 stars
  Buy from Supplier

90
Cell Systems Corporation human primary retinal microvascular endothelial acbri 181 cells
a The changes of [Ca 2+ ]i in <t>HGECs</t> exposed to cinacalcet and high-glucose media. To determine whether the addition of cinacalcet might modulate [Ca 2+ ]i in HGECs, FURA-2AM-loaded HGECs were stimulated using different concentrations (15, 100 nM) of cinacalcet in low-glucose (LG; 5 mmol/l D-glucose) or high-glucose (HG; 30 mmol/l D-glucose) media. The area under curve (AUC) was estimated from the baseline of normalized data (at the point of injection) to a fluorescence level and between time points of injection (0 min) and 10 min. The peak of the curve was measured as highest value of the curve. The peak amplitude and AUC of [Ca 2+ ]i were significantly increased by cinacalcet in dose-dependent manners in both LG and HG media. In Fig. 1a, the arrow denotes the administration of cinacalcet (15 and 100 nM, respectively) ( n = 6 independent experiments in each experiments). * p < 0.05; ** p < 0.01 compared with LG and HG. b The changes of intracellular signaling in HGECs exposed to cinacalcet and high-glucose media. Representative immunofluorescent ( n = 6 independent experiments in each experiments) and western blot analyses ( n = 4 independent experiments in each experiments) of CaSR, CaMKKα/β, phospho-Ser 428 LKB1, and phospho-Thr 172 AMPK in the cultured HGECs in low-glucose (LG; 5 mmol/l D-glucose) or high-glucose (HG; 30 mmol/l D-glucose) conditions with or without cinacalcet treatment (15 nM) and the quantitative analyses of the results are shown. * P < 0.05; ** P < 0.01 and # P < 0.001 compared with other groups
Human Primary Retinal Microvascular Endothelial Acbri 181 Cells, supplied by Cell Systems Corporation, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/primary+human+glomerular+microvascular+endothelial+cells/human+renal+glomerular+microvascular+endothelial+cells+acbri+128/pmc08809984-33-0-10
Average 90 stars, based on 1 article reviews
human primary retinal microvascular endothelial acbri 181 cells - by Bioz Stars, 2026-09
90/100 stars
  Buy from Supplier

90
BioVector NTCC human renal glomerular microvascular endothelial cell line (hrgec)
Apelin-13 alleviates the higher glucose-induced injury of <t>endothelial</t> cells of <t>glomerular</t> vessels. (A) Cell viability was detected with the Cell Counting Kit-8 assay. (B) hRGECs were detected with the lumen formation experiments (magnification, x4). (C) The expression of AT1R, eNOS, APJ, TGBR, E-cadherin and α-SMA in these cells was determined with the western blotting. * P<0.05, ** P<0.01 and *** P<0.001. AT1R, Ang II type 1 receptor; eNOS, endothelial nitric oxide synthase; APJ, angiotensin domain type 1 receptor-associated proteins; TGBR, transforming growth factor β receptor; α-SMA, α-smooth muscle actin.
Human Renal Glomerular Microvascular Endothelial Cell Line (Hrgec), supplied by BioVector NTCC, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/primary+human+glomerular+microvascular+endothelial+cells/human+renal+glomerular+microvascular+endothelial+cell+line+hrgec/pmc08354312-65-2-13
Average 90 stars, based on 1 article reviews
human renal glomerular microvascular endothelial cell line (hrgec) - by Bioz Stars, 2026-09
90/100 stars
  Buy from Supplier

90
Cell Systems Corporation passage 6 human renal glomerular microvascular endothelial cells (acbri 128
Apelin-13 alleviates the higher glucose-induced injury of <t>endothelial</t> cells of <t>glomerular</t> vessels. (A) Cell viability was detected with the Cell Counting Kit-8 assay. (B) hRGECs were detected with the lumen formation experiments (magnification, x4). (C) The expression of AT1R, eNOS, APJ, TGBR, E-cadherin and α-SMA in these cells was determined with the western blotting. * P<0.05, ** P<0.01 and *** P<0.001. AT1R, Ang II type 1 receptor; eNOS, endothelial nitric oxide synthase; APJ, angiotensin domain type 1 receptor-associated proteins; TGBR, transforming growth factor β receptor; α-SMA, α-smooth muscle actin.
Passage 6 Human Renal Glomerular Microvascular Endothelial Cells (Acbri 128, supplied by Cell Systems Corporation, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/primary+human+glomerular+microvascular+endothelial+cells/passage+6+human+renal+glomerular+microvascular+endothelial+cells++acbri+128/us09351979-732-3-10
Average 90 stars, based on 1 article reviews
passage 6 human renal glomerular microvascular endothelial cells (acbri 128 - by Bioz Stars, 2026-09
90/100 stars
  Buy from Supplier


N/A
GFP-HGMVECs were selected from HGMVECs resistant to puromycin after infected with GFP expressing lentiviral particles. The cells are shipped in frozen vials (the cells are provided @ passage 4-5). Endothelial Growth Medium is recommended for
  Buy from Supplier

N/A
RFP-HGMVECs were selected from HGMVECs resistant to Zeocin after infected with RFP expressing lentiviral particles. The cells are shipped in frozen vials (the cells are provided @ passage 4-5). Endothelial Growth Medium is recommended for
  Buy from Supplier


N/A
Human glomerular microvascular endothelial cells (HGMECs) cover the luminal surface of glomerular capillaries and function to regulate vasomotor tone, blood hemostasis, and filtration of leukocytes. Glomerular endothelial cells are usually flattened and have characteristic 50-100
  Buy from Supplier

Image Search Results


a The changes of [Ca 2+ ]i in HGECs exposed to cinacalcet and high-glucose media. To determine whether the addition of cinacalcet might modulate [Ca 2+ ]i in HGECs, FURA-2AM-loaded HGECs were stimulated using different concentrations (15, 100 nM) of cinacalcet in low-glucose (LG; 5 mmol/l D-glucose) or high-glucose (HG; 30 mmol/l D-glucose) media. The area under curve (AUC) was estimated from the baseline of normalized data (at the point of injection) to a fluorescence level and between time points of injection (0 min) and 10 min. The peak of the curve was measured as highest value of the curve. The peak amplitude and AUC of [Ca 2+ ]i were significantly increased by cinacalcet in dose-dependent manners in both LG and HG media. In Fig. 1a, the arrow denotes the administration of cinacalcet (15 and 100 nM, respectively) ( n = 6 independent experiments in each experiments). * p < 0.05; ** p < 0.01 compared with LG and HG. b The changes of intracellular signaling in HGECs exposed to cinacalcet and high-glucose media. Representative immunofluorescent ( n = 6 independent experiments in each experiments) and western blot analyses ( n = 4 independent experiments in each experiments) of CaSR, CaMKKα/β, phospho-Ser 428 LKB1, and phospho-Thr 172 AMPK in the cultured HGECs in low-glucose (LG; 5 mmol/l D-glucose) or high-glucose (HG; 30 mmol/l D-glucose) conditions with or without cinacalcet treatment (15 nM) and the quantitative analyses of the results are shown. * P < 0.05; ** P < 0.01 and # P < 0.001 compared with other groups

Journal: Cell Death & Disease

Article Title: Cinacalcet-mediated activation of the CaMKKβ-LKB1-AMPK pathway attenuates diabetic nephropathy in db/db mice by modulation of apoptosis and autophagy

doi: 10.1038/s41419-018-0324-4

Figure Lengend Snippet: a The changes of [Ca 2+ ]i in HGECs exposed to cinacalcet and high-glucose media. To determine whether the addition of cinacalcet might modulate [Ca 2+ ]i in HGECs, FURA-2AM-loaded HGECs were stimulated using different concentrations (15, 100 nM) of cinacalcet in low-glucose (LG; 5 mmol/l D-glucose) or high-glucose (HG; 30 mmol/l D-glucose) media. The area under curve (AUC) was estimated from the baseline of normalized data (at the point of injection) to a fluorescence level and between time points of injection (0 min) and 10 min. The peak of the curve was measured as highest value of the curve. The peak amplitude and AUC of [Ca 2+ ]i were significantly increased by cinacalcet in dose-dependent manners in both LG and HG media. In Fig. 1a, the arrow denotes the administration of cinacalcet (15 and 100 nM, respectively) ( n = 6 independent experiments in each experiments). * p < 0.05; ** p < 0.01 compared with LG and HG. b The changes of intracellular signaling in HGECs exposed to cinacalcet and high-glucose media. Representative immunofluorescent ( n = 6 independent experiments in each experiments) and western blot analyses ( n = 4 independent experiments in each experiments) of CaSR, CaMKKα/β, phospho-Ser 428 LKB1, and phospho-Thr 172 AMPK in the cultured HGECs in low-glucose (LG; 5 mmol/l D-glucose) or high-glucose (HG; 30 mmol/l D-glucose) conditions with or without cinacalcet treatment (15 nM) and the quantitative analyses of the results are shown. * P < 0.05; ** P < 0.01 and # P < 0.001 compared with other groups

Article Snippet: Human glomerular endothelial cells (HGECs) were purchased from Anigio-Proteomie (Boston, MA) and subcultured in endo-growth media (Angio-Proteomie, Boston, MA).

Techniques: Injection, Fluorescence, Western Blot, Cell Culture

The effect of cinacalcet on intracellular signaling for AMPK-eNOS oxidative stress and apoptosis in the HGECs cultured in low-glucose (LG; 5 mmol/l D-glucose) or high-glucose (HG; 30 mmol/l D-glucose) conditions with or without cinacalcet treatment (1, 5, 15 nM) ( a–d ). Representative Western blot analyses and quantitative analyses of total AMPK, phosphor-Thr 172 AMPK, total eNOS, phospho-Ser 1177 eNOS ( a , * P < 0.05 and ** P < 0.01 compared with LG control), SOD1 and SOD2 ( b , * P < 0.05 compared with other groups), dihydroethidium expression (as an oxidative stress marker; c , * P < 0.05 and # P < 0.001 compared with other groups), Bcl-2, Bax, and TUNEL-positive HGECs ( e , * P < 0.05 and ** P < 0.01 compared with other groups), and β-actin levels in the cultured HGECs and their quantitative analyses of the results are shown ( n = 4 independent experiments in each experiments). d The effect of BAPTA-AM (25 μM) on cinacalcet-indueced in the HGECs cultured in low-glucose or high-glucose (HG; 30 mmol/l D-glucose) with or without cinacalcet treatment (15 nM). Representative Western blot analyses and quantitative analyses of CaMKKβ, phospho-LKB1, and total LKB1 ( n = 4 independent experiments in each experiments). * P < 0.05 and ** P < 0.01 compared with LG control. f The changes of intracellular signaling related to autophagy in HGECs exposed to cinacalcet and high-glucose media. Representative Western blot analyses and quantitative analyses of beclin-1, LC3-II/LC3-I ratio, and β-actin levels in the cultured HGECs and their quantitative analyses of the results are shown ( n = 4 independent experiments in each experiments). Representative immunofluorescent analyses of LC3 punctae in HGECs and the quantitative analyses of the results are shown ( n = 6 independent experiments in each experiments). ** P < 0.01 compared with other groups

Journal: Cell Death & Disease

Article Title: Cinacalcet-mediated activation of the CaMKKβ-LKB1-AMPK pathway attenuates diabetic nephropathy in db/db mice by modulation of apoptosis and autophagy

doi: 10.1038/s41419-018-0324-4

Figure Lengend Snippet: The effect of cinacalcet on intracellular signaling for AMPK-eNOS oxidative stress and apoptosis in the HGECs cultured in low-glucose (LG; 5 mmol/l D-glucose) or high-glucose (HG; 30 mmol/l D-glucose) conditions with or without cinacalcet treatment (1, 5, 15 nM) ( a–d ). Representative Western blot analyses and quantitative analyses of total AMPK, phosphor-Thr 172 AMPK, total eNOS, phospho-Ser 1177 eNOS ( a , * P < 0.05 and ** P < 0.01 compared with LG control), SOD1 and SOD2 ( b , * P < 0.05 compared with other groups), dihydroethidium expression (as an oxidative stress marker; c , * P < 0.05 and # P < 0.001 compared with other groups), Bcl-2, Bax, and TUNEL-positive HGECs ( e , * P < 0.05 and ** P < 0.01 compared with other groups), and β-actin levels in the cultured HGECs and their quantitative analyses of the results are shown ( n = 4 independent experiments in each experiments). d The effect of BAPTA-AM (25 μM) on cinacalcet-indueced in the HGECs cultured in low-glucose or high-glucose (HG; 30 mmol/l D-glucose) with or without cinacalcet treatment (15 nM). Representative Western blot analyses and quantitative analyses of CaMKKβ, phospho-LKB1, and total LKB1 ( n = 4 independent experiments in each experiments). * P < 0.05 and ** P < 0.01 compared with LG control. f The changes of intracellular signaling related to autophagy in HGECs exposed to cinacalcet and high-glucose media. Representative Western blot analyses and quantitative analyses of beclin-1, LC3-II/LC3-I ratio, and β-actin levels in the cultured HGECs and their quantitative analyses of the results are shown ( n = 4 independent experiments in each experiments). Representative immunofluorescent analyses of LC3 punctae in HGECs and the quantitative analyses of the results are shown ( n = 6 independent experiments in each experiments). ** P < 0.01 compared with other groups

Article Snippet: Human glomerular endothelial cells (HGECs) were purchased from Anigio-Proteomie (Boston, MA) and subcultured in endo-growth media (Angio-Proteomie, Boston, MA).

Techniques: Cell Culture, Western Blot, Control, Expressing, Marker, TUNEL Assay

Immunoblot for CaMKKβ, LKB1, phospho-AMPK, SIRT1 and phospho-Ser 1177 eNOS in AMPKα1 siRNA, AMPKα2 siRNA, or SIRT1 siRNA knock-down HGECs in a high-glucose environment with cinacalcet treatment ( a and b ). The cultured HGECs were transfected with a final concentration of 50 nM CaMKKβ and LKB1, α1 and α2-AMPK, SIRT1 siRNAs for 24-h by transfection reagent and treated with cinacalcet (15 nM) in high-glucose media. Representative Western blot analyses of CaMKKβ and phospho-Ser 428 LKB1 ( a ), as well as phospho-Thr 172 AMPK, total AMPK, SIRT1, phospho-Ser 1177 eNOS ( b ) and β-actin levels and the quantitative analyses of the results are also shown ( a and b , respectively) ( n = 4 independent experiments in each experiments).* P < 0.05, ** P < 0.01 compared with control siRNA with HG

Journal: Cell Death & Disease

Article Title: Cinacalcet-mediated activation of the CaMKKβ-LKB1-AMPK pathway attenuates diabetic nephropathy in db/db mice by modulation of apoptosis and autophagy

doi: 10.1038/s41419-018-0324-4

Figure Lengend Snippet: Immunoblot for CaMKKβ, LKB1, phospho-AMPK, SIRT1 and phospho-Ser 1177 eNOS in AMPKα1 siRNA, AMPKα2 siRNA, or SIRT1 siRNA knock-down HGECs in a high-glucose environment with cinacalcet treatment ( a and b ). The cultured HGECs were transfected with a final concentration of 50 nM CaMKKβ and LKB1, α1 and α2-AMPK, SIRT1 siRNAs for 24-h by transfection reagent and treated with cinacalcet (15 nM) in high-glucose media. Representative Western blot analyses of CaMKKβ and phospho-Ser 428 LKB1 ( a ), as well as phospho-Thr 172 AMPK, total AMPK, SIRT1, phospho-Ser 1177 eNOS ( b ) and β-actin levels and the quantitative analyses of the results are also shown ( a and b , respectively) ( n = 4 independent experiments in each experiments).* P < 0.05, ** P < 0.01 compared with control siRNA with HG

Article Snippet: Human glomerular endothelial cells (HGECs) were purchased from Anigio-Proteomie (Boston, MA) and subcultured in endo-growth media (Angio-Proteomie, Boston, MA).

Techniques: Western Blot, Knockdown, Cell Culture, Transfection, Concentration Assay, Control

Apelin-13 alleviates the higher glucose-induced injury of endothelial cells of glomerular vessels. (A) Cell viability was detected with the Cell Counting Kit-8 assay. (B) hRGECs were detected with the lumen formation experiments (magnification, x4). (C) The expression of AT1R, eNOS, APJ, TGBR, E-cadherin and α-SMA in these cells was determined with the western blotting. * P<0.05, ** P<0.01 and *** P<0.001. AT1R, Ang II type 1 receptor; eNOS, endothelial nitric oxide synthase; APJ, angiotensin domain type 1 receptor-associated proteins; TGBR, transforming growth factor β receptor; α-SMA, α-smooth muscle actin.

Journal: International Journal of Molecular Medicine

Article Title: Apelin-13 alleviates diabetic nephropathy by enhancing nitric oxide production and suppressing kidney tissue fibrosis

doi: 10.3892/ijmm.2021.5008

Figure Lengend Snippet: Apelin-13 alleviates the higher glucose-induced injury of endothelial cells of glomerular vessels. (A) Cell viability was detected with the Cell Counting Kit-8 assay. (B) hRGECs were detected with the lumen formation experiments (magnification, x4). (C) The expression of AT1R, eNOS, APJ, TGBR, E-cadherin and α-SMA in these cells was determined with the western blotting. * P<0.05, ** P<0.01 and *** P<0.001. AT1R, Ang II type 1 receptor; eNOS, endothelial nitric oxide synthase; APJ, angiotensin domain type 1 receptor-associated proteins; TGBR, transforming growth factor β receptor; α-SMA, α-smooth muscle actin.

Article Snippet: A human renal glomerular microvascular endothelial cell line (hRGEC) was obtained from the BioVector NTCC, Inc. and cultured in RPMI-1640 medium (Thermo Fisher Scientific, Inc.), supplemented with 10% fetal bovine serum (FBS) in humidified air at 37°C with 5% CO 2 .

Techniques: Cell Counting, Expressing, Western Blot

Apelin-13 relieves the injury of endothelial cells of glomerular vessels by suppressing fibrosis. (A) Cell viability of endothelial cells of glomerular vessels was determined with Cell Counting Kit-8 assay. (B) hRGECs were detected with the lumen formation experiments (magnification, x4). (C) The levels of AT1R, eNOS, APJ, TGBR, E-cadherin and α-SMA in these cells were determined with western blotting. * P<0.05, ** P<0.01 and *** P<0.001. AT1R, Ang II type 1 receptor; eNOS, endothelial nitric oxide synthase; APJ, angiotensin domain type 1 receptor-associated proteins; TGBR, transforming growth factor β receptor; α-SMA, α-smooth muscle actin.

Journal: International Journal of Molecular Medicine

Article Title: Apelin-13 alleviates diabetic nephropathy by enhancing nitric oxide production and suppressing kidney tissue fibrosis

doi: 10.3892/ijmm.2021.5008

Figure Lengend Snippet: Apelin-13 relieves the injury of endothelial cells of glomerular vessels by suppressing fibrosis. (A) Cell viability of endothelial cells of glomerular vessels was determined with Cell Counting Kit-8 assay. (B) hRGECs were detected with the lumen formation experiments (magnification, x4). (C) The levels of AT1R, eNOS, APJ, TGBR, E-cadherin and α-SMA in these cells were determined with western blotting. * P<0.05, ** P<0.01 and *** P<0.001. AT1R, Ang II type 1 receptor; eNOS, endothelial nitric oxide synthase; APJ, angiotensin domain type 1 receptor-associated proteins; TGBR, transforming growth factor β receptor; α-SMA, α-smooth muscle actin.

Article Snippet: A human renal glomerular microvascular endothelial cell line (hRGEC) was obtained from the BioVector NTCC, Inc. and cultured in RPMI-1640 medium (Thermo Fisher Scientific, Inc.), supplemented with 10% fetal bovine serum (FBS) in humidified air at 37°C with 5% CO 2 .

Techniques: Cell Counting, Western Blot